Bausch Health Cos Total Non-Operating Income/Expense 2010-2024 | BHC
Bausch Health Cos total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Bausch Health Cos Annual Total Non-Operating Income/Expense (Millions of US $) |
2023 |
$-1,353 |
2022 |
$-583 |
2021 |
$-1,474 |
2020 |
$-1,610 |
2019 |
$-1,634 |
2018 |
$-1,770 |
2017 |
$-1,843 |
2016 |
$-1,869 |
2015 |
$-1,682 |
2014 |
$-947 |
2013 |
$-905 |
2012 |
$-474 |
2011 |
$-318 |
2010 |
$-126 |
2009 |
$-6 |
Bausch Health Cos Quarterly Total Non-Operating Income/Expense (Millions of US $) |
2024-09-30 |
$-339 |
2024-06-30 |
$-341 |
2024-03-31 |
$-350 |
2023-12-31 |
$-369 |
2023-09-30 |
$-340 |
2023-06-30 |
$-333 |
2023-03-31 |
$-311 |
2022-12-31 |
$-113 |
2022-09-30 |
$195 |
2022-06-30 |
$-290 |
2022-03-31 |
$-375 |
2021-12-31 |
$-346 |
2021-09-30 |
$-358 |
2021-06-30 |
$-400 |
2021-03-31 |
$-370 |
2020-12-31 |
$-389 |
2020-09-30 |
$-385 |
2020-06-30 |
$-410 |
2020-03-31 |
$-426 |
2019-12-31 |
$-394 |
2019-09-30 |
$-395 |
2019-06-30 |
$-436 |
2019-03-31 |
$-409 |
2018-12-31 |
$-451 |
2018-09-30 |
$-417 |
2018-06-30 |
$-489 |
2018-03-31 |
$-413 |
2017-12-31 |
$-482 |
2017-09-30 |
$-438 |
2017-06-30 |
$-417 |
2017-03-31 |
$-506 |
2016-12-31 |
$-510 |
2016-09-30 |
$-469 |
2016-06-30 |
$-458 |
2016-03-31 |
$-432 |
2015-12-31 |
$-434 |
2015-09-30 |
$-454 |
2015-06-30 |
$-406 |
2015-03-31 |
$-388 |
2014-12-31 |
$-54 |
2014-09-30 |
$-307 |
2014-06-30 |
$-234 |
2014-03-31 |
$-352 |
2013-12-31 |
$-302 |
2013-09-30 |
$-250 |
2013-06-30 |
$-182 |
2013-03-31 |
$-172 |
2012-12-31 |
$-177 |
2012-09-30 |
$-119 |
2012-06-30 |
$-104 |
2012-03-31 |
$-75 |
2011-12-31 |
$-71 |
2011-09-30 |
$-100 |
2011-06-30 |
$-75 |
2011-03-31 |
$-72 |
2010-12-31 |
$-85 |
2010-09-30 |
$-22 |
2010-06-30 |
$-9 |
2010-03-31 |
$-10 |
2009-12-31 |
$-11 |
2009-09-30 |
$-10 |
2009-06-30 |
$17 |
2009-03-31 |
$-2 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$3.439B |
$8.757B |
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|